Michael A. Swanson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Michael A. Swanson has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Curtis R. Coughlin
Section of Clinical Genetics and Metabolism, Department of Pediatrics University of Colorado Anschutz Medical Campus Aurora Colorado USA
4 shared publications - Johan L. K. Van Hove
Department of Pediatrics, Section of Clinical Genetics and Metabolism, University of Colorado, Aurora, CO 80045, USA
2 shared publications - Marisa W. Friederich
Department of Pediatrics, Section of Clinical Genetics and Metabolism, University of Colorado, Aurora, USA
2 shared publications Ana M. Brás-Goldberg
Newborn Screening and Biochemical Genetics, Birmingham Children's Hospital, Birmingham, UK
1 shared publication- Arnaud Vanlander
Department of Internal Medicine and Pediatrics, Division of Pediatric Neurology and Metabolism, Ghent University, Ghent, Belgium
1 shared publication - Austin Larson
Department of Pediatrics, University of Colorado School of Medicine, Aurora
1 shared publication
Latest Publications
- 5 June 2024
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 47 (5) , 971-990
Deep postnatal phenotyping of a new mouse model of nonketotic hyperglycinemia
Nonketotic hyperglycinemia due to deficient glycine cleavage enzyme activity causes a severe neonatal epileptic encephalopathy. Current therapies based on mitigating glycine excess have only limited impact. An animal model with postnatal phenotyping is needed to explore new therapeutic approaches. We developed a Gldc p.Ala394Val mutant model and bred it to congenic status in two colonies on C57Bl/6J (B6) and J129X1/SvJ (J129) backgrounds. Mutant mice had reduced P‐protein and enzyme activity indicating a hypomorphic mutant. Glycine levels were increased in blood and brain regions, exacerbated by dietary glycine, with higher levels in female than male J129 mice. Birth defects were more prevalent in mutant B6 than J129 mice, and hydrocephalus was more frequent in B6 (40%) compared to J129 (none). The hydrocephalus rate was increased by postnatal glycine challenge in B6 mice, more so when delivered from the first neonatal week than from the fourth. Mutant mice had reduced weight gain following weaning until the eighth postnatal week, which was exacerbated by glycine loading. The electrographic spike rate was increased in mutant mice following glycine loading, but no seizures were observed. The alpha/delta band intensity ratio was decreased in the left cortex in female J129 mice, which were less active in an open field test and explored less in a Y‐maze, suggesting an encephalopathic effect. Mutant mice showed no evidence of memory dysfunction. This partial recapitulation of human symptoms and biochemistry will facilitate the evaluation of new therapeutic approaches with an early postnatal time window likely most effective.
- 5 June 2024
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 47 (5) , 971-990
Deep postnatal phenotyping of a new mouse model of nonketotic hyperglycinemia
Nonketotic hyperglycinemia due to deficient glycine cleavage enzyme activity causes a severe neonatal epileptic encephalopathy. Current therapies based on mitigating glycine excess have only limited impact. An animal model with postnatal phenotyping is needed to explore new therapeutic approaches. We developed a Gldc p.Ala394Val mutant model and bred it to congenic status in two colonies on C57Bl/6J (B6) and J129X1/SvJ (J129) backgrounds. Mutant mice had reduced P‐protein and enzyme activity indicating a hypomorphic mutant. Glycine levels were increased in blood and brain regions, exacerbated by dietary glycine, with higher levels in female than male J129 mice. Birth defects were more prevalent in mutant B6 than J129 mice, and hydrocephalus was more frequent in B6 (40%) compared to J129 (none). The hydrocephalus rate was increased by postnatal glycine challenge in B6 mice, more so when delivered from the first neonatal week than from the fourth. Mutant mice had reduced weight gain following weaning until the eighth postnatal week, which was exacerbated by glycine loading. The electrographic spike rate was increased in mutant mice following glycine loading, but no seizures were observed. The alpha/delta band intensity ratio was decreased in the left cortex in female J129 mice, which were less active in an open field test and explored less in a Y‐maze, suggesting an encephalopathic effect. Mutant mice showed no evidence of memory dysfunction. This partial recapitulation of human symptoms and biochemistry will facilitate the evaluation of new therapeutic approaches with an early postnatal time window likely most effective.
- Open Access
- 1 December 2017
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 122 (4) , 172-181
New insights into the phenotype of FARS2 deficiency
- 1 December 2017
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 122 (4) , 172-181
Open AccessNew insights into the phenotype of FARS2 deficiency
- 26 September 2017
- Published by Elsevier in Pediatric Neurology
- Vol. 79, e1
Comment on Late-Onset Nonketotic Hyperglycinemia With a Heterozygous Novel Point Mutation of the GLDC Gene
- 26 September 2017
- Published by Elsevier in Pediatric Neurology
- Vol. 79, e1
Comment on Late-Onset Nonketotic Hyperglycinemia With a Heterozygous Novel Point Mutation of the GLDC Gene
- 1 June 2017
- Published by Elsevier in Pediatric Neurology
- Vol. 71, 65-69
X-Linked Cobalamin Disorder ( HCFC1 ) Mimicking Nonketotic Hyperglycinemia With Increased Both Cerebrospinal Fluid Glycine and Methylmalonic Acid
- 1 June 2017
- Published by Elsevier in Pediatric Neurology
- Vol. 71, 65-69
X-Linked Cobalamin Disorder ( HCFC1 ) Mimicking Nonketotic Hyperglycinemia With Increased Both Cerebrospinal Fluid Glycine and Methylmalonic Acid
- 1 January 2017
- Published by Elsevier in Genetics in Medicine
- Vol. 19 (1) , 104-111
The genetic basis of classic nonketotic hyperglycinemia due to mutations in GLDC and AMT
- 1 January 2017
- Published by Elsevier in Genetics in Medicine
- Vol. 19 (1) , 104-111
The genetic basis of classic nonketotic hyperglycinemia due to mutations in GLDC and AMT
- Open Access
- 11 January 2016
- Published by Wiley in Annals of Neurology
- Vol. 79 (3) , 505
Corrigendum: Swanson MA, Coughlin CRJr, Scharer GH, et al: Biochemical and molecular predictors for prognosis in nonketotic hyperglycinemia. Ann Neurol 2015;78:606-618.
- 11 January 2016
- Published by Wiley in Annals of Neurology
- Vol. 79 (3) , 505
Open AccessCorrigendum: Swanson MA, Coughlin CRJr, Scharer GH, et al: Biochemical and molecular predictors for prognosis in nonketotic hyperglycinemia. Ann Neurol 2015;78:606-618.